In the BioHarmony Drug Report Database

"Preview" Icon

Oxiglutatione

Navstel (oxiglutatione) is a small molecule pharmaceutical. Oxiglutatione was first approved as Navstel on 2008-07-24. The pharmaceutical is active against glutathione reductase, mitochondrial. In addition, it is known to target glutathione S-transferase Mu 2. Navstel’s patent is valid until 2021-11-29 (FDA).

 

Trade Name

 

Navstel
 

Common Name

 

oxiglutatione
 

ChEMBL ID

 

CHEMBL1372
 

Indication

 

 

Drug Class

 

Image (chem structure or protein)

Oxiglutatione structure rendering